back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2016-06-10 Tx date 2016-06-09 |
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) |
Melnyk, Eugene
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-175,603.80
-1,463,365 vol $0.12 each |
20,913,418 | |
| Filed 2016-06-10 Tx date 2016-06-01 |
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) |
Melnyk, Eugene
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-25,225.10
-193,000 vol $0.1307 each |
23,478,783 | |
| Filed 2016-06-10 Tx date 2016-06-01 |
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) |
Melnyk, Eugene
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-13,702.50
-101,500 vol $0.135 each |
23,377,283 | |
| Filed 2016-06-10 Tx date 2016-06-03 |
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) |
Melnyk, Eugene
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-26,260
-202,000 vol $0.13 each |
23,175,283 | |
| Filed 2016-06-10 Tx date 2016-06-03 |
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) |
Melnyk, Eugene
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-2,622
-20,000 vol $0.1311 each |
23,155,283 | |
| Filed 2016-06-10 Tx date 2016-06-03 |
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) |
Melnyk, Eugene
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,417.50
-10,500 vol $0.135 each |
23,144,783 | |
| Filed 2016-06-10 Tx date 2016-06-07 |
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) |
Melnyk, Eugene
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-47,645
-366,500 vol $0.13 each |
22,778,283 | |
| Filed 2016-06-10 Tx date 2016-06-07 |
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) |
Melnyk, Eugene
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-202.50
-1,500 vol $0.135 each |
22,776,783 | |
| Filed 2016-06-10 Tx date 2016-06-08 |
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) |
Melnyk, Eugene
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-11,000
-88,000 vol $0.125 each |
22,688,783 | |
| Filed 2016-06-10 Tx date 2016-06-08 |
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) |
Melnyk, Eugene
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-40,560
-312,000 vol $0.13 each |
22,376,783 | |
| Filed 2016-06-10 Tx date 2016-03-17 |
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) |
Melnyk, Eugene
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-32,040
-400,500 vol $0.08 each |
28,927,783 | |
| Filed 2016-06-10 Tx date 2016-03-17 |
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) |
Melnyk, Eugene
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-19,975
-235,000 vol $0.085 each |
28,692,783 | |
| Filed 2016-06-10 Tx date 2016-03-17 |
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) |
Melnyk, Eugene
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-24,795
-275,500 vol $0.09 each |
28,417,283 | |
| Filed 2016-06-10 Tx date 2016-03-17 |
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) |
Melnyk, Eugene
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-8,455
-89,000 vol $0.095 each |
28,328,283 | |
| Filed 2016-06-10 Tx date 2016-03-21 |
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) |
Melnyk, Eugene
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-54,280
-678,500 vol $0.08 each |
27,649,783 | |
| Filed 2016-06-10 Tx date 2016-03-21 |
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) |
Melnyk, Eugene
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-701.25
-8,500 vol $0.0825 each |
27,641,283 | |
| Filed 2016-06-10 Tx date 2016-03-21 |
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) |
Melnyk, Eugene
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-7,650
-90,000 vol $0.085 each |
27,551,283 | |
| Filed 2016-06-10 Tx date 2016-03-21 |
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) |
Melnyk, Eugene
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,925
-22,000 vol $0.0875 each |
27,529,283 | |
| Filed 2016-06-10 Tx date 2016-03-21 |
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) |
Melnyk, Eugene
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-16,830
-187,000 vol $0.09 each |
27,342,283 | |
| Filed 2016-06-10 Tx date 2016-03-21 |
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) |
Melnyk, Eugene
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,330
-14,000 vol $0.095 each |
27,328,283 | |
| Filed 2016-06-10 Tx date 2016-03-31 |
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) |
Melnyk, Eugene
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-54,280
-678,500 vol $0.08 each |
||
| Filed 2016-06-10 Tx date 2016-03-31 |
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) |
Melnyk, Eugene
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-54,280
-678,500 vol $0.08 each |
||
| Filed 2016-06-10 Tx date 2016-03-31 |
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) |
Melnyk, Eugene
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-701.25
-8,500 vol $0.0825 each |
||
| Filed 2016-06-10 Tx date 2016-03-31 |
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) |
Melnyk, Eugene
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-701.25
-8,500 vol $0.0825 each |
||
| Filed 2016-06-10 Tx date 2016-05-10 |
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) |
Melnyk, Eugene
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-47,550
-317,000 vol $0.15 each |
27,011,283 | |
| Filed 2016-06-10 Tx date 2016-05-10 |
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) |
Melnyk, Eugene
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-12,400
-80,000 vol $0.155 each |
26,931,283 | |
| Filed 2016-06-10 Tx date 2016-05-10 |
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) |
Melnyk, Eugene
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-20,480
-128,000 vol $0.16 each |
26,803,283 | |
| Filed 2016-06-10 Tx date 2016-05-10 |
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) |
Melnyk, Eugene
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-3,630
-22,000 vol $0.165 each |
26,781,283 | |
| Filed 2016-06-10 Tx date 2016-05-10 |
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) |
Melnyk, Eugene
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-2,635
-15,500 vol $0.17 each |
26,765,783 | |
| Filed 2016-06-10 Tx date 2016-05-11 |
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) |
Melnyk, Eugene
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-22,620
-156,000 vol $0.145 each |
26,609,783 | |
| Filed 2016-06-10 Tx date 2016-05-11 |
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) |
Melnyk, Eugene
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-16,425
-109,500 vol $0.15 each |
26,500,283 | |
| Filed 2016-06-10 Tx date 2016-05-11 |
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) |
Melnyk, Eugene
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-2,635
-17,000 vol $0.155 each |
26,483,283 | |
| Filed 2016-06-10 Tx date 2016-05-11 |
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) |
Melnyk, Eugene
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,920
-12,000 vol $0.16 each |
26,471,283 | |
| Filed 2016-06-10 Tx date 2016-05-11 |
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) |
Melnyk, Eugene
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-10,725
-65,000 vol $0.165 each |
26,406,283 | |
| Filed 2016-06-10 Tx date 2016-05-16 |
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) |
Melnyk, Eugene
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-7,750
-50,000 vol $0.155 each |
26,356,283 | |
| Filed 2016-06-10 Tx date 2016-05-16 |
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) |
Melnyk, Eugene
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-18,080
-113,000 vol $0.16 each |
26,243,283 | |
| Filed 2016-06-10 Tx date 2016-05-16 |
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) |
Melnyk, Eugene
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-47,025
-285,000 vol $0.165 each |
25,958,283 | |
| Filed 2016-06-10 Tx date 2016-05-16 |
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) |
Melnyk, Eugene
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-8,840
-52,000 vol $0.17 each |
25,906,283 | |
| Filed 2016-06-10 Tx date 2016-05-19 |
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) |
Melnyk, Eugene
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-27,825
-185,500 vol $0.15 each |
25,720,783 | |
| Filed 2016-06-10 Tx date 2016-05-19 |
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) |
Melnyk, Eugene
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-11,547.50
-74,500 vol $0.155 each |
25,646,283 | |
| Filed 2016-06-10 Tx date 2016-05-19 |
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) |
Melnyk, Eugene
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-12,880
-80,500 vol $0.16 each |
25,565,783 | |
| Filed 2016-06-10 Tx date 2016-05-19 |
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) |
Melnyk, Eugene
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,650
-10,000 vol $0.165 each |
25,555,783 | |
| Filed 2016-06-10 Tx date 2016-05-19 |
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) |
Melnyk, Eugene
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-23,471.50
-149,500 vol $0.157 each |
25,406,283 | |
| Filed 2016-06-10 Tx date 2016-05-20 |
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) |
Melnyk, Eugene
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-59,914.80
-396,000 vol $0.1513 each |
||
| Filed 2016-06-10 Tx date 2016-05-20 |
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) |
Melnyk, Eugene
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-59,914.80
-396,000 vol $0.1513 each |
||
| Filed 2016-06-10 Tx date 2016-05-20 |
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) |
Melnyk, Eugene
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-43,650
-291,000 vol $0.15 each |
25,115,283 | |
| Filed 2016-06-10 Tx date 2016-05-20 |
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) |
Melnyk, Eugene
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-16,275
-105,000 vol $0.155 each |
25,010,283 | |
| Filed 2016-06-10 Tx date 2016-05-24 |
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) |
Melnyk, Eugene
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,690
-13,000 vol $0.13 each |
24,997,283 | |
| Filed 2016-06-10 Tx date 2016-05-24 |
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) |
Melnyk, Eugene
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-2,620
-20,000 vol $0.131 each |
24,977,283 | |
| Filed 2016-06-10 Tx date 2016-05-24 |
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) |
Melnyk, Eugene
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-810.00
-6,000 vol $0.135 each |
24,971,283 | |
| Filed 2016-06-10 Tx date 2016-05-24 |
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) |
Melnyk, Eugene
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-10,850
-77,500 vol $0.14 each |
24,893,783 | |
| Filed 2016-06-10 Tx date 2016-05-24 |
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) |
Melnyk, Eugene
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-5,760
-40,000 vol $0.144 each |
24,853,783 | |
| Filed 2016-06-10 Tx date 2016-05-24 |
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) |
Melnyk, Eugene
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-8,047.50
-55,500 vol $0.145 each |
24,798,283 | |
| Filed 2016-06-10 Tx date 2016-05-24 |
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) |
Melnyk, Eugene
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-17,475
-116,500 vol $0.15 each |
24,681,783 | |
| Filed 2016-06-10 Tx date 2016-05-24 |
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) |
Melnyk, Eugene
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-17,592.50
-113,500 vol $0.155 each |
24,568,283 | |
| Filed 2016-06-10 Tx date 2016-05-24 |
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) |
Melnyk, Eugene
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-2,340
-15,000 vol $0.156 each |
24,553,283 | |
| Filed 2016-06-10 Tx date 2016-05-24 |
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) |
Melnyk, Eugene
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,520
-9,500 vol $0.16 each |
24,543,783 | |
| Filed 2016-06-10 Tx date 2016-05-25 |
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) |
Melnyk, Eugene
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-14,430
-111,000 vol $0.13 each |
24,432,783 | |
| Filed 2016-06-10 Tx date 2016-05-25 |
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) |
Melnyk, Eugene
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-6,345
-47,000 vol $0.135 each |
24,385,783 | |
| Filed 2016-06-10 Tx date 2016-05-25 |
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) |
Melnyk, Eugene
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-3,808
-28,000 vol $0.136 each |
24,357,783 | |
| Filed 2016-06-10 Tx date 2016-05-25 |
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) |
Melnyk, Eugene
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-16,100
-115,000 vol $0.14 each |
24,242,783 | |
| Filed 2016-06-10 Tx date 2016-05-25 |
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) |
Melnyk, Eugene
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-25,311
-177,000 vol $0.143 each |
24,065,783 | |
| Filed 2016-06-10 Tx date 2016-05-25 |
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) |
Melnyk, Eugene
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,160
-8,000 vol $0.145 each |
24,057,783 | |
| Filed 2016-06-10 Tx date 2016-05-25 |
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) |
Melnyk, Eugene
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-2,100
-14,000 vol $0.15 each |
24,043,783 | |
| Filed 2016-06-10 Tx date 2016-05-31 |
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) |
Melnyk, Eugene
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-22,680
-162,000 vol $0.14 each |
23,881,783 | |
| Filed 2016-06-10 Tx date 2016-05-31 |
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) |
Melnyk, Eugene
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-652.50
-4,500 vol $0.145 each |
23,877,283 | |
| Filed 2016-06-10 Tx date 2016-06-01 |
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) |
Melnyk, Eugene
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-26,715
-205,500 vol $0.13 each |
23,671,783 | |
| Filed 2016-01-08 Tx date 2016-01-05 |
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) |
Melnyk, Eugene
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,705
-11,000 vol $0.155 each |
29,706,783 | |
| Filed 2016-01-08 Tx date 2016-01-05 |
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) |
Melnyk, Eugene
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-11,440
-71,500 vol $0.16 each |
29,635,283 | |
| Filed 2016-01-08 Tx date 2016-01-05 |
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) |
Melnyk, Eugene
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-4,590
-27,000 vol $0.17 each |
29,608,283 | |
| Filed 2016-01-08 Tx date 2016-01-05 |
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) |
Melnyk, Eugene
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-262.50
-1,500 vol $0.175 each |
29,606,783 | |
| Filed 2016-01-08 Tx date 2016-01-05 |
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) |
Melnyk, Eugene
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-5,130
-28,500 vol $0.18 each |
29,578,283 | |
| Filed 2016-01-08 Tx date 2016-01-06 |
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) |
Melnyk, Eugene
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-29,250
-195,000 vol $0.15 each |
29,383,283 | |
| Filed 2016-01-08 Tx date 2016-01-06 |
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) |
Melnyk, Eugene
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-6,510
-42,000 vol $0.155 each |
29,341,283 | |
| Filed 2016-01-08 Tx date 2016-01-06 |
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) |
Melnyk, Eugene
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-2,080
-13,000 vol $0.16 each |
29,328,283 | |
| Filed 2016-01-08 Tx date 2016-01-05 |
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) |
Melnyk, Eugene
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-16,575
-110,500 vol $0.15 each |
29,717,783 |